Company news
Rapid Dose Therapeutics Corp (CSE:DOSE) news
Rapid Dose Therapeutics Corp news releases on 6ix. Latest, Oct 5, 2026: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt…
Press releases & updates
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt and Proposed Issuance of Shares as Payment of Accrued Director Fees
October 5, 2026
Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy
August 20, 2026
Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada
July 28, 2026
Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization
July 7, 2026
Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets
April 13, 2026
Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory
March 26, 2026
Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market
March 5, 2026
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform
February 23, 2026
Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors
February 11, 2026
Rapid Dose Therapeutics Launches QuickStrip(TM) Medical Cannabis for Patients in Brazil following ANVISA Approval of Sublingual and Buccal Formats for Medical Treatment
February 10, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
January 5, 2026
Rapid Dose Completes Extension to Promissory Notes
December 7, 2025
Rapid Dose Announces Extension to Promissory Notes
November 27, 2025
Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner
October 20, 2025
DEEP Earth Energy Production Corp. Names Christine Hrudka and Wayne Brownlee to its Board of Directors, Appoints John Povhe as CFO and Promotes Ashley Drobot to Vice President of Corporate Development
September 25, 2025
Rapid Dose Therapeutics Submits QuickStrip(TM) Nicotine Product for Health Canada Approval
August 4, 2025
Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip(TM) to Combat Opiate Addiction Crisis
July 29, 2025
Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees
July 3, 2025
Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors
June 2, 2025
Rapid Dose Announces Proposed Equity Private Placement Financing
May 27, 2025
Rapid Dose Therapeutics and Aavishkar Oral Strips File Two Key Patents for Innovative Nicotine Delivery Technology
May 26, 2025
Rapid Dose Announces Proposed Debt Settlement
May 9, 2025
Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research
April 8, 2025
Rapid Dose Therapeutics to Showcase Xylistrip, a Dental Product, at Key Tradeshows Across Canada
April 3, 2025
Rapid Dose Therapeutics Corp. Announces Payment in Shares for Quarterly Interest on Secured Debt and Update on Shares for Debt Settlement with Creditors
March 31, 2025
Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement Financing
February 18, 2025